Professional paper
The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?
Anton Sculean
Adrian Kašaj
Britta Willershausen
Full text: croatian pdf 90 Kb
page 215-222
downloads: 709
cite
APA 6th Edition
Sculean, A., Kašaj, A. & Willershausen, B. (2004). The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?. Acta stomatologica Croatica, 38 (3), 223-228. Retrieved from https://hrcak.srce.hr/1493
MLA 8th Edition
Sculean, Anton, et al. "The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?." Acta stomatologica Croatica, vol. 38, no. 3, 2004, pp. 223-228. https://hrcak.srce.hr/1493. Accessed 18 Apr. 2024.
Chicago 17th Edition
Sculean, Anton, Adrian Kašaj and Britta Willershausen. "The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?." Acta stomatologica Croatica 38, no. 3 (2004): 223-228. https://hrcak.srce.hr/1493
Harvard
Sculean, A., Kašaj, A., and Willershausen, B. (2004). 'The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?', Acta stomatologica Croatica, 38(3), pp. 223-228. Available at: https://hrcak.srce.hr/1493 (Accessed 18 April 2024)
Vancouver
Sculean A, Kašaj A, Willershausen B. The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?. Acta stomatologica Croatica [Internet]. 2004 [cited 2024 April 18];38(3):223-228. Available from: https://hrcak.srce.hr/1493
IEEE
A. Sculean, A. Kašaj and B. Willershausen, "The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?", Acta stomatologica Croatica, vol.38, no. 3, pp. 223-228, 2004. [Online]. Available: https://hrcak.srce.hr/1493. [Accessed: 18 April 2024]
Full text: english pdf 78 Kb
page 223-228
downloads: 662
cite
APA 6th Edition
Sculean, A., Kašaj, A. & Willershausen, B. (2004). The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?. Acta stomatologica Croatica, 38 (3), 223-228. Retrieved from https://hrcak.srce.hr/1493
MLA 8th Edition
Sculean, Anton, et al. "The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?." Acta stomatologica Croatica, vol. 38, no. 3, 2004, pp. 223-228. https://hrcak.srce.hr/1493. Accessed 18 Apr. 2024.
Chicago 17th Edition
Sculean, Anton, Adrian Kašaj and Britta Willershausen. "The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?." Acta stomatologica Croatica 38, no. 3 (2004): 223-228. https://hrcak.srce.hr/1493
Harvard
Sculean, A., Kašaj, A., and Willershausen, B. (2004). 'The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?', Acta stomatologica Croatica, 38(3), pp. 223-228. Available at: https://hrcak.srce.hr/1493 (Accessed 18 April 2024)
Vancouver
Sculean A, Kašaj A, Willershausen B. The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?. Acta stomatologica Croatica [Internet]. 2004 [cited 2024 April 18];38(3):223-228. Available from: https://hrcak.srce.hr/1493
IEEE
A. Sculean, A. Kašaj and B. Willershausen, "The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?", Acta stomatologica Croatica, vol.38, no. 3, pp. 223-228, 2004. [Online]. Available: https://hrcak.srce.hr/1493. [Accessed: 18 April 2024]
Abstract
The goal of regenerative periodontal therapy is the reconstitution of the lost periodontal structures (i.e. the new formation of root cementum, periodontal ligament and alveolar bone). Results from basic research have pointed to the important role of the enamel matrix protein derivative (EMD) in periodontal wound healing. Histological results of experiments in animals and of human case reports have shown that treatment with EMD promotes periodontal regeneration. Moreover, clinical studies have indicated that treatment with EMD positively influences periodontal wound healing in humans. The goal of the current overview is to present, based on the existing evidence, the clinical indications for regenerative therapy with EMD.
Keywords
enamel matrix protein derivative; cementogenesis; surgical periodontal therapy; periodontal regeneration
Hrčak ID:
1493
URI
https://hrcak.srce.hr/1493
Publication date:
15.9.2004.
Article data in other languages:
croatian
Visits: 2.460
*
